Recomendaciones de "No Hacer"

Guía de práctica clínica para el manejo de pacientes con gota. 2020. Grupo GuipClinGot de trabajo de la GPC para el Manejo de Pacientes con Gota. Guía de práctica clínica. https://www.ser.es/wpcontent/uploads/2020/10/Gui%CC%81a-de-Pra%CC%81ctica-Cli%CC%81nica-para-el-manejo-de-la-Gota.pdf

Beslon V, Moreau P, Maruani A, Maisonneuve H, Giraudeau B, Fournier JP. Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review. J Gen Intern Med. 2018 Mar;33(3):358-366. doi:10.1007/s11606-017-4233-5. Epub 2017 Dec 4. PMID: 29204974; PMCID: PMC5834964.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Lioté F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707.
Epub 2016 Jul 25. PMID: 27457514.

Perez-Ruiz F, Herrero-Beites AM, Carmona L. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis. Arthritis Rheum. 2011 Dec;63(12):4002-6. doi: 10.1002/art.30649. PMID:21898351.

Perez-Ruiz F, Atxotegi J, Hernando I, Calabozo M, Nolla JM. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study. Arthritis Rheum. 2006 Oct 15;55(5):786-90. doi: 10.1002/art.22232. PMID: 17013833.

Masip GM, Prada MF, López EB. Técnicas de administración de las vacunas [Internet]. Fisterra. 2022 [citado el 11 de noviembre de 2024]. Disponible en: htips://www-fisterra-com.na-cdib.a 17.csinet.es/guias-clinicas/tecnicasadministracionˇvacunas/#sec4

Comité Asesor de Vacunas e Inmunizaciones. Capítulo 5 - El acto de la inmunización: antes, durante y después [Internet]. Manual de inmunizaciones en línea de la AEP. 2023 [citado el 10 de noviembre de 2024]. Disponible en: htips://vacunasaep.org/documentos/manual /cap-5#4.

Wong H, Moss C, Moss SM, Shah V, Halperin SA, Ito S, Mithal P, Qu A, Taddio A. Effect of alcohol skin cleansing on vaccination-associated infections and local skin reactions: a randomized controlled trial. Human Vaccines & Immunotherapeutics. doi: 10.1080/21645515.2018.1553474. Epub 2019 Jan 16.

Australian Government/Department of Health Care and Aged Care – Australian Inmmunisation Handbook. htips://www.health.gov.au/resources/publications/theˇaustralian-immunisation-handbook?language=en. Guía oficial publicada por el Departamento de Salud del Reino Unido “Green Book” “Immunisation against infectious disease” (acceso a la guía: htips://www.gov.uk/government/collections/immunisation-against-infectious-diseaseˇthegreen-book). En el capítulo 4: “Immunisation procedures”, apartado “Cleaning de skin”: htips://assets.publishing.service.gov.uk/media/5a7afc62e5274a34770e88e5/GreenˇBookChapter-4.pdf. If the skin is clean, no further cleaning is necessary. Only visibly dirty skin needs to be washed with soap and water. It is not necessary to disinfect the skin. Studies have shown that cleaning the skin with isopropyl alcohol reduces the bacterial count, but there is evidence that disinfecting makes no difference to the incidence of bacterial complications of injections (Del Mar et al., 2001; Sution et al., 1999).

Fisterra. “Técnicas de administración de vacunas” htips://www.fisterra.com/guiasclinicas/tecnicas-administracion-vacunas/ Limpiar la piel con suero fisiológico y dejar secar. No usar alcohol, ya que puede inactivar las vacunas de virus vivos atenuados. En general, no se recomienda el uso de clorhexidina alcohólica o acuosa. Tampoco povidona yodada para la preparación de la piel. Nueva solicitud de inclusión de RNH 2 de 4 07/04/2025, 10:55

Vaccine Administration Best Practices. Lafleur B, Fung J, Verschoor CP, Dubois S, MacDonald NE, Taddio A. Omission of alcohol skin cleansing and risk of adverse events in long-term care residents undergoing COVID-19 vaccination: A cohort study. Hum Vaccin Immunother. 2024 Dec 31;20(1):2368681. doi: 10.1080/21645515.2024.2368681. Epub 2024 Jul 2. PMID: 38953297; PMCID: PMC11221462.

Dulong C, Breti K, Argáez C. Skin Preparation for Injections: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines [Internet]. Otiawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Mar. PMID: 33074639

Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 2021 . Hall E., Wodi A.P., Hamborsky J., et al., eds. Guía de práctica clínica. Pinkbook 14th ed. Washington, D.C. Public Health Foundation. Disponible en: https://www.merle-arbeitsmedizin.de/wpcontent/uploads/2022/02/CDC-PinkBook-Version-14th-Edition.pdf

Standard immunizations for nonpregnant adults. UpToDate. 2024. Hibberd PL. Guía de práctica clínica. Disponible en: https://www-uptodatecom.na-cdib.a17.csinet.es/contents/standard-immunizations-fornonpregnantadults?search=vaccunation%20recomendations&source=search_result&selected

Ponencia de Programa y Registro de Vacunaciones. Calendario acelerado de vacunaciones. 2023. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad. Guía de práctica clínica.

Manual de inmunizaciones y vacunaciones de Euskadi, 5ª edición. 2024. Guía de práctica clínica. Disponible en: (https://www.euskadi.eus/contenidos/informacion/manual_vacunaciones/es_def/adjunt
os/MANUAL-VACUNACIONES-2024.pdf).

Sociedad Española de Geriatría y Gerontología - Recomendaciones de vacunación para adultos y mayores. 2023-2024. Guía de práctica clínica.Disponible en: (https://www.segg.es/pdfViewer/web/viewer.asp?archivo=vacunacion).

Comité Asesor de Vacunas e Inmunizaciones - Intervalos y compatibilidad entre Inmunizaciones. Guía de práctica clínica . Disponible en: https://vacunasaep.org/printpdf/profesionales/intervalos-ycompatibilidadentre-vacunas

Recomendaciones generales sobre vacunación. Recomendaciones del Comité Asesor sobre Prácticas de Inmunización (ACIP). Guía de práctica clínica. Disponible en: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm

Consideraciones generales y calendario básico de vacunaciones en el adulto. Guía de práctica clínica. Fisterra. Disponible en: https://www.fisterra.com/guias-clinicas/consideraciones-generales-calendariobasicovacunaciones-adulto/#sec3

General Best Practice Guidance for Immunization. 2021. Chapter 2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J (eds.). 14th ed. Washington DC: Public Health Foundation, 2021.

Seguridad de las vacunas. Contraindicaciones y precauciones. 2023. Comité Asesor de Vacunas e Inmunizaciones (CAV-AEP). Manual de vacunas en línea de la AEP [Internet]. Madrid: AEP; dic/2023.

Vaccination procedures. 2022. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health and Aged Care, Canberra, 2022.

Public Health Agency of Canada. Chapter 2: CContraindications and precautions associated with specific conditions.2021 .Canadian Immunization Guide [Internet]. Ottawa (ON): Government of Canada; Date of publication/last update (2021/11) Available from: https://www.canada.ca/en/publichealth/services/publications/healthy-living/canadian-immunization-guide-part-2-vaccine-safety/page-3-contraindications-precautions-concerns.html

Vaccination & Immunoprophylaxis— General Principles, Andrew Kroger, Mark Freedman. CDC Yellow Book 2024. https://wwwnc.cdc.gov/travel/yellowbook/2024/preparing/vaccination-andimmunoprophylaxis-general-principles#acute

Meaney, P.A. et al. (2013) ‘Cardiopulmonary resuscitation quality: Improving cardiac resuscitation outcomes both inside and outside the hospital’, Circulation, 128(4), pp. 417–435. doi:10.1161/cir.0b013e31829d8654.

Jones SI, Jeffers JM, Perretta J, et al. Closing the gap: optimizing performance to reduce interruptions in cardiopulmonary resuscitation. Pediatr Crit Care Med 2020;21:e592 _8, doi:http://dx. doi.org/10.1097/PCC.0000000000002345.

Zakka T, Papler H, Pêgo-Fernandes PM. Chronic pain: A big challenge. Sao Paulo Med J. 2024 Feb
19;142(1):e20231421. doi: 10.1590/1516-3180.2024.1421.131223. PMID: 38381877

Lurie JM, Javaid A. Visualizing Global Chronic Pain. Anesth Analg. 2024 Apr 1;138(4):918-9. doi:
10.1213/ANE.0000000000006564. Epub 2024 Mar 15.PMID: 38489798

Dydyk AM, Conermann T. Chronic Pain. Chronic Diseases: An Encyclopedia of Causes, Effects, and
Treatments: Volume 1: A-H/ Volume 2: I-Z [Internet]. 2024 May 6 [citado 2024 Jun 17];599-601. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK553030/

Sovaila S, Purcarea A, Neculau A. Chronic pain, a narrative review for the internist in 2024. Rom J Intern Med. 2023 Dec 28;62(2):124-37. doi: 10.2478/rjim-2023-0035. PMID: 38153854

Agodi, A., Auxilia, F., Barchitta, M., Cristina, M. L., D’Alessandro, D., Mura, I., Nobile, M., Pasquarella, C., Avondo, S., Bellocchi, P., Canino, R., Capozzi, C., Casarin, R., Cavasin, M., Contegiacomo, P., Deriu, M. G., Evola, F. R., Farsetti, P., Grandi, A.,Vitali, P. (2015). Operating theatre ventilation systems and microbial air contamination in total joint replacement surgery: Results of the GISIO-ISChIA study. Journal of Hospital Infection, 90(3), 213–219. https://doi.org/10.1016/j.jhin.2015.02.014

Astier, P., Gost, J., Redín, J. M., Manrique, A., Lameiro, F. J., & Echeverría, J. M. (2000). Program for minimising biological risks associated with hospital infrastructure: Functions, activities, responsibilities; [Programa de minimizacion de riesgos biologicos asociados a la infraestructura hospitalaria: Funciones, actividades, responsabilidades]. Anales Del Sistema Sanitario de Navarra, 23(SUPPL. 2), 205–226.

Bamber, S., Haiduven, D., & Denning, D. W. (2025). Survey of current national and international guidance to reduce risk of aspergillosis in hospitals. Journal of Hospital Infection, 159, 124–139. https://doi.org/10.1016/j.jhin.2025.02.015

Birgand, G., Toupet, G., Rukly, S., Antoniotti, G., Deschamps, M.-N., Lepelletier, D., Pornet, C., Stern, J. B., Vandamme, Y.-M., van der Mee-Marquet, N., Timsit, J.-F., & Lucet, J.-C. (2015). Air contamination for predicting wound contamination in clean surgery: A large multicenter study. American Journal of Infection Control, 43(5), 516–521. https://doi.org/10.1016/j.ajic.2015.01.026.

Chiletzari, S., Barbouni, A., & Kesanopoulos, K. (2025). Impact of Microbial Load on Operating Room Air Quality and Surgical Site Infections: A Systematic Review. Acta Microbiologica Hellenica (Switzerland), 70(2). https://doi.org/10.3390/amh70020020

Colella, Y., Valente, A. S., Rossano, L., Trunfio, T. A., Fiorillo, A., & Improta, G. (2022). A Fuzzy Inference System for the Assessment of Indoor Air Quality in an Operating Room to Prevent Surgical Site Infection. International Journal of Environmental Research and Public Health, 19(6). https://doi.org/10.3390/ijerph19063533

Coury, J. G., Lum, Z. C., Dunn, J. G., Huff, K. E., Lara, D. L., & Trzeciak, M. A. (2021). Operating room and hospital air environment. Orthopedics

Crimi, P., Argellati, F., Macrina, G., Tinteri, C., Copello, L., Rebora, D., Romania, L., & Rizzetto, R. (2006). Microbiological surveillance of hospital ventilation systems in departments at high risk of nosocomial infections. Journal of Preventive Medicine and Hygiene, 47(3), 105–109.

Cristina, M. L., Spagnolo, A. M., Ottria, G., Schinca, E., Dupont, C., Carbone, A., Oliva, M., & Sartini, M. (2021). Microbial air monitoring in turbulent airflow operating theatres: Is it possible to calculate and hypothesize new benchmarks for microbial air load? International Journal of Environmental Research and Public Health, 18(19). https://doi.org/10.3390/ijerph181910379

Dallolio, L., Raggi, A., Sanna, T., Mazzetti, M., Orsi, A., Zanni, A., Farruggia, P., & Leoni, E. (2018). Surveillance of environmental and procedural measures of infection control in the operating theatre setting. International Journal of Environmental Research and Public Health, 15(1). https://doi.org/10.3390/ijerph15010046

Dharan, S., & Pittet, D. (2002). Environmental controls in operating theatres. Journal of Hospital Infection, 51(2), 79–84. https://doi.org/10.1053/jhin.2002.1217

Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., Gaztelurrutia, L., Navarro, J. I. v, & Tudela, J. L. R. (2000). Genetic similarity among one Aspergillus flavus strain isolated from a patient who underwent heart surgery and two environmental strains obtained from the operating room. JOURNAL OF CLINICAL MICROBIOLOGY, 38(6), 2419–2422.

Facciola, A., Pellicano, G. F., Visalli, G., Paolucci, I. A., Rullo, E. V., Ceccarelli, M., D’Aleo, F., di Pietro, A., Squeri, R., Nunnari, G., & la Fauci, V. (2019). The role of the hospital environment in the healthcare-associated infections: a general review of the literature. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 23(3), 1266–1278.

Hardy, S., & Haas, J. P. (2008). Infection Prevention for Construction and Renovation in the Operating Room. Perioperative Nursing Clinics, 3(2), 137–142. https://doi.org/10.1016/j.cpen.2008.01.004

Heinemann, S., Symoens, F., Gordts, B., Jannes, H., & Nolard, N. (2004). Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. Journal of Hospital Infection, 57(2), 149–155. https://doi.org/10.1016/j.jhin.2004.02.007

Humphreys, H., Bak, A., Ridgway, E., Wilson, A. P. R., Vos, M. C., Woodhead, K., Haill, C., Xuereb, D., Walker, J. M., Bostock, J., Marsden, G. L., Pinkney, T., Kumar, R., & Hoffman, P. N. (2023). Rituals and behaviours in the operating theatre – joint guidelines of the Healthcare Infection Society and the European Society of Clinical Microbiology and Infectious Diseases. Journal of Hospital Infection, 140, 165.e1-165.e28. https://doi.org/10.1016/j.jhin.2023.06.009

Kronman, M. P., Baden, H. P., Jeffries, H. E., Heath, J., Cohen, G. A., & Zerr, D. M. (2007). An investigation of Aspergillus cardiac surgical site infections in 3 pediatric patients. American Journal of Infection Control, 35(5), 332–337. https://doi.org/10.1016/j.ajic.2006.10.013

Leung, M., & Chan, A. H. S. (2006). Control and management of hospital indoor air quality. Medical Science Monitor, 12(3), SR17–SR23. https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644698248&partnerID=40&md5=9efeeb1052de03d5e3647591385b33ac

Lutz, B. D., Jin, J. K., Rinaldi, M. G., Wickes, B. L., & Huycke, M. M. (2003). Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system. CLINICAL INFECTIOUS DISEASES, 37(6), 786–793. https://doi.org/10.1086/377537

Martín Salas, C., Tordoya Titichoca, I. J., & Ezpeleta Baquedano, C. (2016). Control microbiológico ambiental. Enfermedades Infecciosas y Microbiologia Clinica, 34, 19–24. https://doi.org/10.1016/S0213-005X(16)30215-4

Masia, M. D., Dettori, M., Deriu, G. M., Soddu, S., Deriu, M., Arghittu, A., Azara, A., & Castiglia, P. (2021). Microbial monitoring as a tool for preventing infectious risk in the operating room: Results of 10 years of activity. Atmosphere, 12(1), 1–10. https://doi.org/10.3390/atmos12010019

Montagna, M. T., Rutigliano, S., Trerotoli, P., Napoli, C., Apollonio, F., D’Amico, A., de Giglio, O., Diella, G., Lopuzzo, M., Marzella, A., Mascipinto, S., Pousis, C., Albertini, R., Pasquarella, C., D’Alessandro, D., Serio, G., & Caggiano, G. (2019). Evaluation of air contamination in orthopaedic operating theatres in hospitals in Southern Italy: The IMPACT project. International Journal of Environmental Research and Public Health, 16(19). https://doi.org/10.3390/ijerph16193581

Oulkheir, S., Safouan, H., el Housse, F., Aghrouch, M., Ounine, K., Douira, A., & Chadli, S. (2021). Assessment of microbiological indoor air quality in a public hospital in the city of Agadir, Morocco. Periodicum Biologorum, 123(1–2), 29–34. https://doi.org/10.18054/pb.v123i1-2.6461

Pakshir, K., Shekarkhar, G., Mostagnie, S., Sabayan, B., & Vaghefikia, A. (2007). Monitoring of airborne fungi in two general hospitals in Shiraz, southern Iran. Iranian Journal of Medical Sciences, 32(4), 240–244. https://www.scopus.com/inward/record.uri?eid=2-s2.0-39449099635&partnerID=40&md5=bafd58745921488b4e37ac1fa6b56efe

Pasqualotto, A. C., & Denning, D. W. (2006). Post-operative aspergillosis. Clinical Microbiology and Infection, 12(11), 1060–1076. https://doi.org/10.1111/j.1469-0691.2006.01512.x

Patterson JE, Peters J, Calhoon JH, Levine S, Anzueto A, Al-Abdely H, Sanchez R, Patterson TF, Rech M, Jorgensen JH, Rinaldi MG, Sako E, Johnson S, Speeg V, Halff GA, Trinkle JK. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2000 Mar;2(1):22-8. doi: 10.1034/j.1399-3062.2000.020105.x. PMID: 11429006.

Pelaez, T., Munoz, P., Guinea, J., Valerio, M., Giannella, M., Klaassen, C. H. W., & Bouza, E. (2012). Outbreak of Invasive Aspergillosis After Major Heart Surgery Caused by Spores in the Air of the Intensive Care Unit. CLINICAL INFECTIOUS DISEASES, 54(3), E24–E31. https://doi.org/10.1093/cid/cir771

Persson, M. (2019). Airborne contamination and surgical site infection: Could a thirty-year-old idea help solve the problem? Medical Hypotheses, 132. https://doi.org/10.1016/j.mehy.2019.109351

Robles Garcia, M., Dierssen Sotos, T., Llorca Diaz, F. J., Rodriguez Cundin, P., & Roiz Mesones, M. P. (2005). Prevention of nosocomial infection of fungal origin:: verification of the environmental biosafety in surgery rooms. REVISTA CLINICA ESPANOLA, 205(12), 601–606. https://doi.org/10.1016/S0014-2565(05)72653-9

Sehulster, L., & Chinn, R. Y. W. (2003). Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports / Centers for Disease Control, 52(RR-10), 1–42.

Tateiwa, T., Masaoka, T., Takahashi, Y., Ishida, T., Shishido, T., & Yamamoto, K. (2024). Unveiling the dynamics of intraoperative contamination in total hip arthroplasty: the discrepancy between particulate and microbial contamination in surgical site infection risk. Arthroplasty, 6(1). https://doi.org/10.1186/s42836-024-00272-0

de Oliveira, M. T., Batista, N. K. R., de Souza Gil, E., do Rosário Rodrigues Silva, M., Costa, C. R., Bara, M. T. F., & Torres, I. M. S. (2020). Risks associated with pathogenic fungi isolated from surgical centers, intensive care units, and materials sterilization center in hospitals. Risks associated with pathogenic fungi isolated from critical hospital areas. Medical Mycology, 58(7), 881–886. https://doi.org/10.1093/mmy/myaa004

Hagiya H, Otsuka F. Increased evidence for no benefit of contact precautions in preventing extended-spectrum β-lactamases-producing Enterobacteriaceae: Systematic scoping review. Am J Infect Control. 2023;51(9):1056-62. doi: 10.1016/j.ajic.2023.01.018. PMID: 36736903.

Thompson P, Teter J, Atrubin K. Incidence of health care-associated extended-spectrum β-lactamase-positive patients before and after discontinuation of contact precautions. Am J Infect Control. 2020;48(1):52-5. doi: 10.1016/j.ajic.2019.06.016. PMID: 31358415.

Maechler F, Schwab F, Hansen S, Fankhauser C, Harbarth S, Huttner BD, Diaz-Agero C, Lopez N, Canton R, Ruiz-Garbajosa P, Blok H, Bonten MJ, Kloosterman F, Schotsman J, Cooper BS, Behnke M, Golembus J, Kola A, Gastmeier P; R-GNOSIS WP5 study group. Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial. Lancet Infect Dis. 2020;20(5):575-84. doi: 10.1016/S1473-3099(19)30626-7. PMID: 32087113.

Gottlieb LB, Walits E, Patel G, Schaefer S. Taking off the gown: Impact of discontinuing contact precautions for extended-spectrum β-lactamase (ESBL)-producing organisms. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e31. doi: 10.1017/ash.2021.189. PMID: 36168477; PMCID: PMC9495408.

Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls CMJE, de Brauwer EIGB, Buiting AGM, Diederen BM, van Elzakker EPM, Friedrich AW, Hopman J, Al Naiemi N, Rossen JWA, Ruijs GJHM, Savelkoul PHM, Verhulst C, Vos MC, Voss A, Bonten MJM, Kluytmans JAJW; SoM Study Group. Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study. Lancet Infect Dis. 2019;19(10):1069-79. doi: 10.1016/S1473-3099(19)30262-2. PMID: 31451419.

Souverein D, Euser SM, Herpers BL, Hattink C, Houtman P, Popma A, Kluytmans J, Rossen JWA, Den Boer JW. No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitals. Antimicrob Resist Infect Control. 2017;6:69. doi: 10.1186/s13756-017-0228-6. PMID: 28670449; PMCID: PMC5485576.

Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S. Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review. Clin Infect Dis. 2017;65(2):342-7. doi: 10.1093/cid/cix258. PMID: 28379311.

Tschudin-Sutter S, Frei R, Schwahn F, Tomic M, Conzelmann M, Stranden A, Widmer AF. Prospective Validation of Cessation of Contact Precautions for Extended-Spectrum β-Lactamase-Producing Escherichia coli(1). Emerg Infect Dis. 2016 Jun;22(6):1094-7. doi: 10.3201/eid2206.150554. PMID: 27191171; PMCID: PMC4880108.

Metan G, Metin BC, Baştuğ Z, Tekin İ, Aytaç H, Çınar B, Zengin H, Ünal S. Cessation of Contact Precautions for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Seems to be Safe in a Nonepidemic Setting. Infect Control Hosp Epidemiol. 2017;38(11):1379-81. doi: 10.1017/ice.2017.198. Epub 2017 Sep 20. PMID: 28927480.

Zahar JR, Poirel L, Dupont C, Fortineau N, Nassif X, Nordmann P. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15:512. doi: 10.1186/s12879-015-1244-x. PMID: 26563141; PMCID: PMC4642679.

Bellini C, Eder M, Senn L, Sommerstein R, Vuichard-Gysin D, Schmiedel Y, Schlegel M, Harbarth S, Troillet N. Providing care to patients in contact isolation: is the systematic use of gloves still indicated? Swiss Med Wkly. 2022;152:w30110. doi: 10.4414/smw.2022.w30110. PMID: 35147391.

Li X, Shao Q, Shen J, Ren S, Li L, Lu H, Chen S. Association between the initial dose urate-lowering drugs and gout flares in adult males with gout. Rheumatology (Oxford). 2024 May 3;63(6):1599-1606. doi: 10.1093/rheumatology/kead437. PMID: 37610331.

[Guía de práctica clínica para el manejo de pacientes con gota] [2020] [Grupo GuipClinGot de trabajo de la GPC para el Manejo de Pacientes con Gota] [Guía de práctica clínica]. https://www.ser.es/wp-content/uploads/2020/10/Gui%CC%81a-de-Pra%CC%81ctica-Cli%CC%81nica-parael-Manejo-de-la-Gota.pdf

Yamanaka H, Tamaki S, Ide Y, Kim H, Inoue K, Sugimoto M, Hidaka Y, Taniguchi A, Fujimori S, Yamamoto T. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study. Ann Rheum Dis. 2018 Feb;77(2):270-276. doi: 10.1136/annrheumdis-2017-211574. Epub 2017 Nov 4. PMID: 29102957; PMCID: PMC5867413.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Lioté F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25. PMID: 27457514.

Stamp LK, Frampton C, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Doherty M, Zhang W, Richardson H,
Sarmanova A, Christensen R. Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials. Lancet Rheumatol. 2022 Jan;4(1):e53-e60. doi: 10.1016/S2665-9913(21)00319-2.

Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, Baumgartner S. An open-label, 6-month study of allopurinol safety in gout: The LASSO study. Semin Arthritis Rheum. 2015 Oct;45(2):174-83. doi: 10.1016/j.semarthrit.2015.05.005. Epub 2015 May 21. PMID: 26190562.

Rivera Redondo J, Díaz Del Campo Fontecha P, Alegre de Miquel C, Almirall Bernabé M, Casanueva Fernández B, Castillo Ojeda C, et al. Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and Treatment. Reumatol Clin (Engl Ed). 2022 Mar;18(3):131-140.

Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubere JP, Le Lay K, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum. 2008;58:895–902.

Lamotte M, Maugars Y, Le Lay K, Taieb C. Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France. Clin Exp Rheumatol. 2010;28 6 Suppl 63:S64–70.

Aïni K, Curelli-Chéreau A, Antoine P. The subjective experience of patients livingwith fibromyalgia: A qualitative analysis. Annales Medico-Psychologiques. 2010;168:255–62.

Escudero-Carretero MJ, Garcia-Toyos N, Prieto-Rodriguez M.A., Perez-Corral O., March-Cerda J.C., Lopez-Doblas M. Fibromyalgia: Patient perception on their disease and health system. Qualitative research study. Reumatol Clin. 2010;6:16-22.

National Institute for Health and Care Excellence (NICE). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain [Internet]. London: NICE; 2021.